Mirela Olympia Fagarasan Palmer work in academia as an internationally recognized neuropharmacology and neuroimmunology researcher. She published more than 500 scientific reports in the field of neuropsychopharmacology and signal transduction. She is leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. We use genetic, neuroendocrine and neurochemical methods. We recognize the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states she had successfully combined research, teaching, administration and clinical care and continue to work on advancing our understanding of serious mental illness and drug development. They used to translate research findings into medical practice for the purposes of diagnosing, preventing and treating diseases. She had published scientific reports on peptides, their receptors, signal transduction and the role of these neuropeptides in the immune systems. She holds patents for using modified peptides in the treatment of septic shock. She had skills and expertise in receptor pharmacology, immunohistochemistry, in vivo and in vitro cell culture, biochemistry, animal models, cell and molecular biology. She had lectured worldwide on these subjects and the others. She had 19 years of research experience with development and use of in vitro models to test compounds, such as receptor binding, receptor activation, signal transduction, receptor-receptor interactions, and induction of changes in cell cycle, proliferation and apoptosis. Furthermore she validated appropriate assays and models of diseases, screen compounds, and study mechanisms of action.